Regulation of mesenchymal stem cell chondrogenesis by glucose through protein kinase C/transforming growth factor signaling

Osteoarthritis and Cartilage

Volumn 21, Issue 2, 2013, Pages 368-376

  Tsai, T L ^a,b   Manner, P A ^c   Li, W J ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Madison   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chondrogenesis; Mesenchymal stem cell; Pre differentiation culture; Protein kinase C; Transforming growth factor beta

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; GLUCOSE; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ADULT; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CHONDROGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STEM CELL EXPANSION;

ADULT; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROGENESIS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HUMANS; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 84872668535     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.11.001     Document Type: Article

References (41)

1. Javazon E.H., Beggs K.J., Flake A.W. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 2004, 32:414-425.
2. Barry F.P., Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004, 36:568-584.
3. Jorgensen C., Gordeladze J., Noel D. Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol 2004, 15:406-410.
4. Campagnoli C., Roberts I.A., Kumar S., Bennett P.R., Bellantuono I., Fisk N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001, 98:2396-2402.
5. Erices A., Conget P., Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000, 109:235-242.
6. Kogler G., Sensken S., Airey J.A., Trapp T., Muschen M., Feldhahn N., et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004, 200:123-135.
7. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
8. Alm J.J., Heino T.J., Hentunen T.A., Vaananen H.K., Aro H.T. Transient 100 nM dexamethasone treatment reduces inter- and intraindividual variations in osteoblastic differentiation of bone marrow-derived human mesenchymal stem cells. Tissue Eng Part C Methods 2012.
9. Xiao Y., Peperzak V., van Rijn L., Borst J., de Bruijn J.D. Dexamethasone treatment during the expansion phase maintains stemness of bone marrow mesenchymal stem cells. J Tissue Eng Regen Med 2010, 4:374-386.
10. Chuang C.C., Yang R.S., Tsai K.S., Ho F.M., Liu S.H. Hyperglycemia enhances adipogenic induction of lipid accumulation: involvement of extracellular signal-regulated protein kinase 1/2, phosphoinositide 3-kinase/Akt, and peroxisome prolif-erator-activated receptor gamma signaling. Endocrinology 2007, 148:4267-4275.
11. Aguiari P., Leo S., Zavan B., Vindigni V., Rimessi A., Bianchi K., et al. High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci U S A 2008, 105:1226-1231.
12. Li Y.M., Schilling T., Benisch P., Zeck S., Meissner-Weigl J., Schneider D., et al. Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun 2007, 363:209-215.
13. Han Y.S., Bang O.S., Jin E.J., Park J.H., Sonn J.K., Kang S.S. High dose of glucose promotes chondrogenesis via PKCalpha and MAPK signaling pathways in chick mesenchymal cells. Cell Tissue Res 2004, 318:571-578.
14. Sotiropoulou P.A., Perez S.A., Salagianni M., Baxevanis C.N., Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 2006, 24:462-471.
15. Bian L., Zhai D.Y., Tous E., Rai R., Mauck R.L., Burdick J.A. Enhanced MSC chondrogenesis following delivery of TGF-beta3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo. Biomaterials 2011, 32:6425-6434.
16. Johnstone B., Hering T.M., Caplan A.I., Goldberg V.M., Yoo J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998, 238:265-272.
17. Baddoo M., Hill K., Wilkinson R., Gaupp D., Hughes C., Kopen G.C., et al. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 2003, 89:1235-1249.
18. Sekiya I., Vuoristo J.T., Larson B.L., Prockop D.J. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci U S A 2002, 99:4397-4402.
19. Caplan A.I. Mesenchymal stem cells. J Orthop Res 1991, 9:641-650.
20. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
21. Feng X.H., Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 2005, 21:659-693.
22. Furumatsu T., Ozaki T., Asahara H. Smad3 activates the Sox9-dependent transcription on chromatin. Int J Biochem Cell Biol 2009, 41:1198-1204.
23. Furumatsu T., Tsuda M., Taniguchi N., Tajima Y., Asahara H. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J Biol Chem 2005, 280:8343-8350.
24. Palmer G.D., Steinert A., Pascher A., Gouze E., Gouze J.N., Betz O., et al. Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Mol Ther 2005, 12:219-228.
25. Wang W.G., Lou S.Q., Ju X.D., Xia K., Xia J.H. In vitro chondrogenesis of human bone marrow-derived mesenchymal progenitor cells in monolayer culture: activation by transfection with TGF-beta2. Tissue Cell 2003, 35:69-77.
26. Wu L., Derynck R. Essential role of TGF-beta signaling in glucose-induced cell hypertrophy. Dev Cell 2009, 17:35-48.
27. Yasuda Y., Nakamura J., Hamada Y., Nakayama M., Chaya S., Naruse K., et al. Role of PKC and TGF-beta receptor in glucose-induced proliferation of smooth muscle cells. Biochem Biophys Res Commun 2001, 281:71-77.
28. Lindschau C., Quass P., Menne J., Guler F., Fiebeler A., Leitges M., et al. Glucose-induced TGF-beta1 and TGF-beta receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-alpha. Hypertension 2003, 42:335-341.
29. Mobasheri A., Vannucci S.J., Bondy C.A., Carter S.D., Innes J.F., Arteaga M.F., et al. Glucose transport and metabolism in chondrocytes: a key to understanding chondrogenesis, skeletal development and cartilage degradation in osteoarthritis. Histol Histopathol 2002, 17:1239-1267.
30. Cramer C., Freisinger E., Jones R.K., Slakey D.P., Dupin C.L., Newsome E.R., et al. Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev 2010, 19:1875-1884.
31. Yoshimura N., Muraki S., Oka H., Kawaguchi H., Nakamura K., Akune T. Association of knee osteoarthritis with the accumulation of metabolic risk factors such as overweight, hypertension, dyslipidemia, and impaired glucose tolerance in Japanese men and women: the ROAD study. J Rheumatol 2011, 38:921-930.
32. Davies-Tuck M.L., Wang Y., Wluka A.E., Berry P.A., Giles G.G., English D.R., et al. Increased fasting serum glucose concentration is associated with adverse knee structural changes in adults with no knee symptoms and diabetes. Maturitas 2012, 72:373-378.
33. Hart D.J., Doyle D.V., Spector T.D. Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J Rheumatol 1995, 22:1118-1123.
34. Sturmer T., Brenner H., Brenner R.E., Gunther K.P. Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthritis. The Ulm osteoarthritis study. Scand J Rheumatol 2001, 30:169-171.
35. Arthritis as a potential barrier to physical activity among adults with diabetes - United States, 2005 and 2007. MMWR Morb Mortal Wkly Rep 2008, 57:486-489.
36. Nanney L.B., Paulsen S., Davidson M.K., Cardwell N.L., Whitsitt J.S., Davidson J.M. Boosting epidermal growth factor receptor expression by gene gun transfection stimulates epidermal growth in vivo. Wound Repair Regen 2000, 8:117-127.
37. Ryu J.M., Lee M.Y., Yun S.P., Han H.J. High glucose regulates cyclin D1/E of human mesenchymal stem cells through TGF-beta1 expression via Ca2+/PKC/MAPKs and PI3K/Akt/mTOR signal pathways. J Cell Physiol 2010, 224:59-70.
38. Lee T.S., Saltsman K.A., Ohashi H., King G.L. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A 1989, 86:5141-5145.
39. Pickl M., Ries C.H. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene 2009, 28:461-468.
40. Sankar S., Mahooti-Brooks N., Bensen L., McCarthy T.L., Centrella M., Madri J.A. Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 1996, 97:1436-1446.
41. Kleeff J., Korc M. Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells. J Biol Chem 1998, 273:7495-7500.